𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Session 8: Radiopharmaceutical Chemistry-Halogens II


Publisher
John Wiley and Sons
Year
2003
Tongue
French
Weight
639 KB
Volume
46
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

✦ Synopsis


Recently, there is much interest to label choline with C-11 and F-18 for PET imaging of various tumors. Hara et al. reported the preparation of [ 18 F]fluoroethylcholine (FECh) and DeGrado et al. the synthesis of [ 18 F]fluorocholine (FCH). Both syntheses require sophisticated purification step (preparative purification using ion-pair reagent for FECh and GC purification for FCH). We have designed an approach to prepare FECh and FCH that allows us to use the same equipment that produces FDG. Coenen et al. systematically studied the [ 18 F]fluorination of disubstituted alkanes and found that [ 18 F]fluoroethyl tosylate can be prepared in high yield from ditosylethane, while the corresponding [ 18 F]fluoromethyl tosylate can not prepared in useful yield. The 1-pot 2-step reaction started with [ 18 F]labeling of disulfonate alkane followed by fluorosulfonate intermediate's alkylation with dimethylethanolamine. [ 18 F]fluorination of ditosylethane proceeded efficiently (80%) while the alkylation step was surprisingly average. Thus, FECh overall yield was only 50%, decay corrected. [ 18 F]Fluorination of di-tosylmethane was more delicate. This step, when driven to completion, only yielde d [ 18 F]di-fluoromethane, not the mono-AcOH EtOH/ Water Dimethyl amine D itosyl K222/ Carbonate 3-W a y Valves Argon Reaction Vessel


📜 SIMILAR VOLUMES


Session 3: Radiopharmaceutical Chemistry
📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 811 KB

Positron Emission Tomography (PET) is a high-resolution, sensitive and non-invasive imaging technique that can be used in humans. It is the most advanced technology current ly available for studying in vivo molecular interactions and also represents the method of choice to assess the distribution an

Session 6: Neuroscience II Receptors - C
📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 657 KB

Figure 1, 1a, hNK1 IC 50 = 67pM) is an NK1 receptor PET ligand that was developed in collaboration with the Turku, Uppsala and Hammersmith PET Centers. One drawback of this tracer is its faster rate of defluorination in nonhuman primates than in humans. It was our desire to improve [ 18 F]SPARQ for

Session 2: Oncology: Molecular Markers a
📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 582 KB

## Rationale: Cancer is a proliferative dis ease that stems from genomic modulations at the cellular level and results in overexpression of characteristic proteins on the cell surface. Targeting oncogene mRNA in vivo with a Tc-99m-labeled specific biomolecule could provide a powerful tool for imag

Synthesis of /Tyr-3H/4-angiotensin II an
✍ I. Mezõ; J. A. Seproõi; I. Teplán; J. L. Morgat; P. Fromageot; G. Tóth; F. Sirok 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 French ⚖ 369 KB

## Abstract A method is described for the tritium labelling of angiotensin II in two different positions. /Tyr‐^3^H/^4^‐angiotensin II and /Phe‐^3^H/^8^‐angiotensin II of high specific radioactivity have been prepared starting from Dbt^4^‐angiotensin II and Cpa^8^‐angiotensin II, respectively.

New N6-substituted 8-alkyl-2-phenylmethy
✍ Giuliana Biagi; Irene Giorgi; Oreste Livi; Federica Pacchini; Valerio Scartoni; 📂 Article 📅 2004 🏛 Journal of Heterocyclic Chemistry 🌐 English ⚖ 157 KB

## Abstract Title compounds bearing substituents on C(2), C(6) and C(8) were prepared from a newly synthesized pyrimidine derivative **11.** The new pyrimidine **11** was generated from compound **2** through two different synthetic schemes. In one pathway, compound **2** was nitrosated, reduced an